Osteoprotegerin, Recombinant, Human (OPG, OCIF, Osteoclastogenesis Inhibitory Factor)
Catalog No : USB-220119
471.28€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | Osteoprotegerin, Recombinant, Human (OPG, OCIF, Osteoclastogenesis Inhibitory Factor) | ||
|---|---|---|---|
| Catalog No | USB-220119 | ||
| Supplier’s Catalog No | 220119 | ||
| Supplier | US Biologicals | ||
| Source antigen | Recombinant, E. coli | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | 20 | ||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Highly Purified | ||
| Purity | ~98% (SDS-PAGE, HPLC) | ||
| Form | Supplied as a lyophilized powder. No preservative added. Reconstitute with sterile 5mM Tris, pH 7.5 to 0.1-1mg/ml. | ||
| Reactivity life | 12 months | ||
| Note | For reserch purpose only | ||
| Purity | ~98% (SDS-PAGE, HPLC) | ||
| Description | Human OPG (Osteoprotegerin), also known as OCIF (Osteoclastogenesis inhibitory factor), is a member of the TNF receptor superfamily. Recombinant human OPG/OCIF specifically acts on bone tissues and increases bone mineral density and bone volume associated with a decrease of active osteoclast number. Source: Recombinant protein corresponding to 174aa residues from human OPG, expressed in E. coli. Molecular Weight: ~20kD Biological Activity: Determined by its ability to neutralize the stimulation of U937 cells treated with 10ng/ml of sRANKL. Endotoxin: <0.1ng/ug Storage and Stability: Lyophilized powder may be stored at -20°C. Reconstitute with sterile buffer. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. | ||
Product Details
© 2020 Imugex All Rights Reserved